Skip to main
OBLN
OBLN logo

Obalon Therapeutics (OBLN)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Obalon Therapeutics (OBLN) Stock

About Obalon Therapeutics (OBLN)

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.
Market cap$28.73M
Today's volume9.53K
Revenue (TTM)$4.19M
Avg. daily volume305.88K
EBITDA (TTM)-$5.38M
Open$5.45
Price / earnings ratio-0.03x
Today's range$5.03 - $5.45
Debt / equity1.53x
52 week range$4.44 - $520
5 year debt / equity10.09x
Beta (LTM)-0.62x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio1.94x
Ex-dividend date
Next earningsMay 12, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for OBLN stock is $28.74M

The current P/E ratio for OBLN stock is -0.03

The 52-week high for OBLN stock is $520. The current OBLN stock price $undefined is 100.00% below its 52-week high

The 52-week low for OBLN stock is $4.44. The current OBLN stock price $undefined has increased 100.00% from its 52-week low

No, the OBLN stock does not pay dividends to its shareholders

How to buy OBLN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in OBLN stock

    Navigate to the Explore page. Then, type OBLN into the search bar. When you see OBLN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased OBLN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Obalon Therapeutics Stock Earnings

The value each OBLN share was expected to gain vs. the value that each OBLN share actually gained.

Obalon Therapeutics (OBLN) reported Q3 2020 earnings per share (EPS) of -$0.20, missing estimates of -$0.07 by 185.71%. In the same quarter last year, Obalon Therapeutics's earnings per share (EPS) was $0. Obalon Therapeutics is expected to release next earnings on 05/12/2021, with an earnings per share (EPS) estimate of $0.

Buy Obalon Therapeutics (OBLN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.